Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address andrew.muir@duke.edu
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow in Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2001
  • M.D., Duke University, 1993

Publications

Sanyal, Arun J., Stephen A. Harrison, Vlad Ratziu, Manal F. Abdelmalek, Anna Mae Diehl, Stephen Caldwell, Mitchell L. Shiffman, et al. “The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials..” Hepatology 70, no. 6 (December 2019): 1913–27. https://doi.org/10.1002/hep.30664.

PMID
30993748
Full Text

Muir, Andrew J. “Is Magnetic Resonance Cholangiopancreatography Worth a Thousand Words in Determining Prognoses of Patients With Primary Sclerosing Cholangitis?.” Clin Gastroenterol Hepatol 17, no. 13 (December 2019): 2654–56. https://doi.org/10.1016/j.cgh.2019.04.067.

PMID
31077831
Full Text

Brahmania, Mayur, Manuel Lombardero, Bettina E. Hansen, Norah A. Terrault, Anna S. Lok, Robert P. Perrillo, Steven H. Belle, et al. “Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection..” Clin Gastroenterol Hepatol 17, no. 12 (November 2019): 2541-2551.e2. https://doi.org/10.1016/j.cgh.2019.02.005.

PMID
30743006
Full Text

Ocal, Selin, Andrew J. Muir, and Susanna Naggie. “Hepatitis C Behind and Beyond Bars: Targeting the US Prison Population and Changing North Carolina Prisoner Health Policy..” N C Med J 80, no. 6 (November 2019): 352–55. https://doi.org/10.18043/ncm.80.6.352.

PMID
31685570
Full Text

Dore, Gregory J., Jordan J. Feld, Alex Thompson, Marianne Martinello, Andrew J. Muir, Kosh Agarwal, Beat Müllhaupt, et al. “Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial..” J Hepatol, October 23, 2019. https://doi.org/10.1016/j.jhep.2019.10.010.

PMID
31655134
Full Text

Younossi, Zobair M., Maria Stepanova, Eric J. Lawitz, K Rajender Reddy, Vincent Wai-Sun Wong, Alessandra Mangia, Andrew J. Muir, et al. “Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life..” Am J Gastroenterol 114, no. 10 (October 2019): 1636–41. https://doi.org/10.14309/ajg.0000000000000375.

PMID
31464743
Full Text

Trauner, Michael, Aliya Gulamhusein, Bilal Hameed, Stephen Caldwell, Mitchell L. Shiffman, Charles Landis, Bertus Eksteen, et al. “The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis..” Hepatology 70, no. 3 (September 2019): 788–801. https://doi.org/10.1002/hep.30509.

PMID
30661255
Full Text

Di Bisceglie, Adrian M., Wendy C. King, Mauricio Lisker-Melman, Mandana Khalili, Steven H. Belle, Jordan J. Feld, Marc G. Ghany, et al. “Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B..” J Viral Hepat 26, no. 7 (July 2019): 856–65. https://doi.org/10.1111/jvh.13104.

PMID
30974509
Full Text

Younossi, Zobair M., Maria Stepanova, Ira Jacobson, Andrew J. Muir, Stanislas Pol, Stefan Zeuzem, Ziad Younes, et al. “Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening of Patient-Reported Outcomes..” Clin Infect Dis, April 5, 2019. https://doi.org/10.1093/cid/ciz243.

PMID
30949674
Full Text

Hirschfield, Gideon M., Olivier Chazouillères, Joost P. Drenth, Douglas Thorburn, Stephen A. Harrison, Charles S. Landis, Marlyn J. Mayo, et al. “Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial..” J Hepatol 70, no. 3 (March 2019): 483–93. https://doi.org/10.1016/j.jhep.2018.10.035.

PMID
30414864
Full Text

Pages